Building Effective Partnerships to Power Life Sciences Innovation - SPONSOR CONTENT FROM ASTELLAS
By Tadaaki Taniguchi
For people living with serious diseases, science has the potential to change everything. Twenty-five years into what many have called 'biology's century,' rapid advancements in our understanding of molecular biology, genetics, and biotechnology are unlocking the extraordinary properties of living systems to improve lives and redefine what is possible in medicine.
Exciting advances in immuno-oncology, targeted protein degradation (TPD), and cell and gene therapy, along with precision medicine, hold tremendous promise to transform outcomes for people living with cancer, vision loss, and rare diseases. Realizing the full potential of these exciting new modalities requires collaboration and coordination across the life-science ecosystem—from the bench to the bedside—starting at the earliest stages of drug discovery.
As a trained surgeon who transitioned into a career in the pharmaceutical industry, I've witnessed first-hand the vital importance of collaboration between academia, biotech, and the broader pharmaceutical sector in answering one simple question: How can we better help the next patient?
This is especially true in Massachusetts and the Greater Boston area, where collaboration has played a significant role in driving some of the most important advances in modern medicine.
By partnering with leading institutions like Mass General Brigham, LabCentral, and UMASS Chan Medical School, we can accelerate progress and expand research frontiers by merging drug discovery expertise with academic leadership. Our partnerships extend beyond academic walls, to organizations such as MassBio and the Longwood Fund, which enable us to connect and collaborate with leading innovators doing cutting-edge research.
Successful collaborations are built on open communication and a shared commitment to both risks and rewards. These partnerships thrive when there is a balance between academic freedom and commercial objectives, empowering researchers to drive groundbreaking science within a culture of continuous learning, all while ensuring real-world impact.
This spirit of collaboration is a driving force behind the Astellas Life Sciences Center (ALSC) in Cambridge, Mass., allowing us to tap into the rich insights and experience of the vibrant local life-science community. With 400 employees, ALSC houses such key functions as medical and development, translational medicine, drug discovery, and business development. The ALSC is also home to Astellas' first U.S.-based SakuLab: an open innovation space designed to help us engage with external partners. It joins SakuLab-Tsukuba, the company's first incubator space, located at our flagship research campus in Japan.
By collaborating with biotech companies at the forefront of adeno-associated virus gene therapy research and sharing lab communities such as LabCentral 238 in Boston's Kendall Square, Astellas' strategy is to push the boundaries of science in complex novel areas like cell and gene therapy, oncology, and ophthalmology.
Our work in these complex areas is fueled by our nearby Astellas Institute for Regenerative Medicine, our global hub for pioneering the development and manufacturing of regenerative medicine and cell-based therapies.
These are all key components of our effort to build an innovation network across Massachusetts, connecting biotechnology leaders, academia, and other local partners. By working together, we can drive progress for patients in an ecosystem that is truly greater than the sum of its parts.
Chris Coburn, Chief Innovation Officer at Mass General Brigham, notes the importance of collaboration. 'Innovative partnerships, like ours with Astellas, are pivotal in bridging scientific discovery and real-world patient impact,' he says. 'By uniting academic excellence with industry expertise, we are accelerating advancements in oncology, rare diseases, and cell and gene therapy, creating new opportunities to address unmet medical needs.'
So, how can we better help the next patient? By forging powerful partnerships, we will broaden our pipeline, unlock new treatments, and shape the next generation of life-changing medicines.
Tadaaki Taniguchi is the Chief Research & Development Officer at Astellas Pharma, where he leads the company's global R&D efforts to drive innovation and advance transformative therapies.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Bloomberg
a day ago
- Bloomberg
Harvard AIDS Research, Affiliated Hospitals Hit by Trump Feud
The Trump administration's funding battle with Harvard University is starting to impact projects at affiliated hospitals and has crippled the school's Center for AIDS Research, one of the largest backers in the US for emerging studies on the condition. Harvard funnels a portion of its federal grants to research partners, including the Mass General Brigham hospital system, and that money has now largely stopped flowing after the government froze more than $2.6 billion in support. Mass General researchers whose work is affected should 'stop all activity and spending' unless they have found alternative funding, Paul Anderson, the hospital group's chief academic officer, said in a message to staff late last week.
Yahoo
2 days ago
- Yahoo
Gun deaths among children surge after states loosen firearm laws, new study finds
A new study published Monday in JAMA Pediatrics found that over 7,000 more children died from firearm-related injuries in the years following a 2010 Supreme Court decision that gave states greater power to set their own gun laws. Most of those deaths occurred in states that opted to make it easier to purchase and carry firearms. The study, led by Dr. Jeremy Faust, an emergency medicine doctor with Mass General Brigham, found a sharp increase in gun-related deaths among children and teens ages 0 to 17 beginning in 2011, following the 2010 McDonald v. Chicago decision, which ruled that the Second Amendment's right to bear arms was applicable to all states and municipalities and ultimately overturned municipal handgun bans like the one previously enforced in Chicago. Over the 12-year post-decision period, researchers estimate more than 6,000 excess deaths occurred in states with the most permissive gun laws. Another 1,400 excess deaths occurred in states that made their laws more permissive but were not in the most extreme group. Meanwhile, four states -- California, New York, Maryland, and Rhode Island, all of which had strict laws -- saw significant drops in pediatric gun deaths. Parkland school shooting 7 years later: Remembering the 17 victims "States that made it easier to obtain and carry a firearm had a tradeoff for that, which was a higher rate of mortality in kids," Faust said. Researchers analyzed more than two decades of data, comparing trends in gun-related deaths before and after the legal shift. They adjusted for background trends and compared gun deaths to other causes like motor vehicle accidents, overdoses, and cancer. The increase in deaths was not part of a broader rise in youth mortality -- it was specific to firearms. This wasn't just about overall violence going up, Faust told ABC News. The change in gun deaths was far greater than any other trend the study looked at, including deaths involving motor vehicle accidents, overdose and even cancer, he said. Firearms are now the leading cause of death in children and teens in the United States, a distinction not seen in other developed countries. During the 25-year study period, guns were involved in 4% of all pediatric deaths, outpacing motor vehicle crashes and cancer. The study also found that the increases in firearm deaths were not confined to a single demographic or region. Rates rose in both urban and rural areas, and among all racial and ethnic groups studied. However, non-Hispanic Black children and teens were disproportionately affected in states that had loosened gun laws. Most of the pediatric gun deaths were not accidental. They were homicides and suicides, deaths that might have been prevented with safer policies or better storage laws, according to the study. In fact, researchers noted that unintentional shootings made up a small share of overall deaths. HHS appears to delete Surgeon General gun violence advisory webpage Faust acknowledged that there is no one-size-fits-all solution, and that each state may need tailored approaches to address gun violence. He called for continued research and collaboration with policymakers to determine which gun safety laws save the most lives and emphasized the importance of evidence-based policymaking, comparing gun laws to the nationwide mandates for child car seats. "You can't leave the hospital with a newborn unless you have the right car seat in all 50 states," he noted. "That's because vehicle collisions up until a few years ago were the leading cause of mortality outside of infancy." Dr. Ilan Kokotek is a board-certified family physician completing training in preventive medicine at the Johns Hopkins Bloomberg School of Public Health and is a member of the ABC News Medical Unit. Gun deaths among children surge after states loosen firearm laws, new study finds originally appeared on
2 days ago
Gun deaths among children surge after states loosen firearm laws, new study finds
A new study published Monday in JAMA Pediatrics found that over 7,000 more children died from firearm-related injuries in the years following a 2010 Supreme Court decision that gave states greater power to set their own gun laws. Most of those deaths occurred in states that opted to make it easier to purchase and carry firearms. The study, led by Dr. Jeremy Faust, an emergency medicine doctor with Mass General Brigham, found a sharp increase in gun-related deaths among children and teens ages 0 to 17 beginning in 2011, following the 2010 McDonald v. Chicago decision, which ruled that the Second Amendment's right to bear arms was applicable to all states and municipalities and ultimately overturned municipal handgun bans like the one previously enforced in Chicago. Over the 12-year post-decision period, researchers estimate more than 6,000 excess deaths occurred in states with the most permissive gun laws. Another 1,400 excess deaths occurred in states that made their laws more permissive but were not in the most extreme group. Meanwhile, four states -- California, New York, Maryland, and Rhode Island, all of which had strict laws -- saw significant drops in pediatric gun deaths. "States that made it easier to obtain and carry a firearm had a tradeoff for that, which was a higher rate of mortality in kids," Faust said. Researchers analyzed more than two decades of data, comparing trends in gun-related deaths before and after the legal shift. They adjusted for background trends and compared gun deaths to other causes like motor vehicle accidents, overdoses, and cancer. The increase in deaths was not part of a broader rise in youth mortality -- it was specific to firearms. This wasn't just about overall violence going up, Faust told ABC News. The change in gun deaths was far greater than any other trend the study looked at, including deaths involving motor vehicle accidents, overdose and even cancer, he said. Firearms are now the leading cause of death in children and teens in the United States, a distinction not seen in other developed countries. During the 25-year study period, guns were involved in 4% of all pediatric deaths, outpacing motor vehicle crashes and cancer. The study also found that the increases in firearm deaths were not confined to a single demographic or region. Rates rose in both urban and rural areas, and among all racial and ethnic groups studied. However, non-Hispanic Black children and teens were disproportionately affected in states that had loosened gun laws. Most of the pediatric gun deaths were not accidental. They were homicides and suicides, deaths that might have been prevented with safer policies or better storage laws, according to the study. In fact, researchers noted that unintentional shootings made up a small share of overall deaths. Faust acknowledged that there is no one-size-fits-all solution, and that each state may need tailored approaches to address gun violence. He called for continued research and collaboration with policymakers to determine which gun safety laws save the most lives and emphasized the importance of evidence-based policymaking, comparing gun laws to the nationwide mandates for child car seats. "You can't leave the hospital with a newborn unless you have the right car seat in all 50 states," he noted. "That's because vehicle collisions up until a few years ago were the leading cause of mortality outside of infancy."
